About SSM12

Symposium-2

The 12th Summer School on Medicines (SSM12) will be held in Toulouse, France from July 1 – 8, 2022.

The curriculum of SSM12 covers the whole process of drug R&D, from target to market. Participants will take part in interactive classes, case studies, a visit to a translational medicine research center and a full-day opportunity to network with experts from pharmaceutical companies in the Toulouse area, one of the most active regions in France.

Christopher Lipinski during SSM4 Industrial Symposium

Dr Chris Lipinski, author of the rule of 5 for predicting drug-like structures for oral bioavailability in early discovery, speaking at SSM4 in Montreal (2012).

Discovering a new drug is a complex process that involves a wide range of highly specialized professionals in public institutions and industry, from biologists and chemists to clinicians, economists and regulatory affairs specialists. Since 2009, the Summer School of Medicines has become a benchmark for training in this area.

Max FehlmannSSM12 offers a unique 50-hour training program on drug discovery, development and market access under a multicultural sponsorship in the wonderful setting of Toulouse, France.

Make plans now for one full week of lively presentations and direct interactions with the Faculty, including Case Studies and Workshops with Industry, covering the whole value chain of medicines, from “idea to market”. The Faculty members are leaders in their field and contribute to create one of the most innovative and focused programs in drug discovery and development currently offered.

Each year since 2009, the SSM has involved more than 60 students, professors and research companies, bringing the opportunity to learn about drug discovery process in a multicultural context (the participants come from Canada, France, Spain, Brazil and other countries).


SSM12 – Scientific & Organizing Committee

Chairs: Rémy Poupot and Pierre Cordelier
Paul Sabatier University and Inserm

Scientific Committee:

  • Pierre Cordelier (Inserm, Toulouse, France)
  • Rémy Poupot (Paul Sabatier University, Toulouse, France)
  • Denis deBlois (University of Montreal, Canada)
  • Marçal Pastor-Anglada, Director of the Institute of Biomedicine, University of Barcelona (IBUB)
  • Jordi Quintana (Chemotargets, Barcelona, Catalonia, Spain)
  • Bruno Ségui (Paul Sabatier University and Inserm, Toulouse, France)
  • Vitor Faça (Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brazil) 

Local Organizing Committee:

  • Pierre Cordelier (Inserm, Toulouse, France)
  • Rémy Poupot (Paul Sabatier University, Toulouse, France)
  • Bruno Ségui (Paul Sabatier University and Inserm, Toulouse, France)
  • Lionel Havion (Fondation Toulouse Cancer Santé, Toulouse, France)

SSM12 Partners & Sponsors :